SAN DIEGO, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Kratos Defense & Security Solutions, Inc. (Nasdaq: KTOS), a technology company in Defense, National Security and Global Markets, today announced that ...

Rocket Lab stock is on a roll as launch revenue rolls in and a new Neutron rocket promises to grow revenue even more. Rocket ...

Since closing on the deal to buy Aerojet, Niebergall said L3Harris has increased capital spending for the rocket motor unit ...

In April 2018, Boeing announced its investment in Reaction Engines, through Boeing HorizonX Ventures with a $37.3 million ...

L3Harris Technologies has successfully powered Kratos Defense & Security Solutions’ demonstration test of two advanced, ...

Rocket Lab reports its Q3 earnings on Nov. 12. The fast-growing space flight company is losing a ton of money. Investors should buy if they are comfortable with high-risk stocks in their portfolio.

J.P. Morgan analyst Eric Joseph maintained a Buy rating on Rocket Pharmaceuticals (RCKT – Research Report) yesterday and set a price target of $49.00. The company’s shares closed yesterday at ...

(Nasdaq: KTOS), a technology company in Defense, National Security and Global Markets, today announced that its Zeus 1 and ...

Should you buy the stock before this third-quarter earnings release? Rocket Lab is taking advantage of the booming space economy, which analysts estimate will have over $1 trillion in annual ...

SAN DIEGO, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Kratos Defense & Security Solutions, Inc. (Nasdaq: KTOS), a technology company in Defense, National Security and Global Markets, today announced that its ...